Number of Shares
1.30 Mil
Current Holdings Value*
$43.62 Mil
% of Portfolio
3.11%
Total Estimate Gain
$-9.89 Mil
% of Total Estimate Gain
-18.94%

Vestal Point Capital, LP's Xenon Pharmaceuticals Inc Holding Summary

As of 2025-03-31, Vestal Point Capital, LP held 1.30 Mil shares of Xenon Pharmaceuticals Inc(XENE), totaling $43.62 Mil. This investment constitutes 3.11% of their stock portfolio, and Vestal Point Capital, LP now holds 1.7% of the outstanding Xenon Pharmaceuticals Inc(XENE) stock.

The initial trade took place in 2023Q4. And since then Vestal Point Capital, LP has made 4 purchases of XENE, at an average price of $39.72, for a total of 1.31 Mil shares. In addition, there have been 1 sales at an average price of $41.36 for 15,000.00 shares. Based on historical transaction data and XENE's current price of $32.09, Vestal Point Capital, LP's estimated gain on his XENE holdings is $-9.89 Mil, reflecting a -18.94% gain to date.

Vestal Point Capital, LP XENE ($32.09) Holding Chart

Vestal Point Capital, LP XENE ($32.09) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1